Sir, Koebner's isomorphic phenomenon refers to the development of new lesions of a dermatosis (clinically and pathologically similar to the pre-existing dermatosis) at previously uninvolved sites after trauma. It has been classically described with psoriasis, vitiligo, and lichen planus, and is thought to represent active disease. 1 Reports of Koebner's phenomenon occurring in autoimmune bullous disorders are uncommon. Here, we report a case of bullous pemphigoid who developed Koebner's phenomenon at the site of tuberculin skin test.
were no chronic inflammatory cell infiltrate, epitheloid cells or giant cells to suggest a positive hypersensitivity reaction to purified protein derivative.
Koebner's phenomenon has been classically described with psoriasis, lichen planus, and vitiligo. 1 Koebner's phenomenon described in autoimmune vesiculobullous diseases has been classified as questionable in view of isolated and rare case reports. 1 It has been previously described in pemphigus vulgaris 2 and pemphigus foliaceous. 3 It has been postulated that trauma leads to exposure of autoantigens with subsequent antibody-mediated response and bulla formation. There are reports of generalized bullous pemphigoid occurring after orthopedic surgery and radiotherapy with onset of disease at the the site of surgery or irradiation, respectively. Bullous pemphigoid arising at the site of vein-graft harvest on the legs has also been described. 4 Pemphigus vulgaris koebnerizing at the site of tuberculin skin test site has been reported previously. 5 The authors proposed that the local inflammatory milieu produced by intradermal injection of purified protein derivative (interleukin-1α, interleukin-1β, tumor necrosis factorα) at 72 hours is similar to that occurring naturally in the pathogenesis of autoimmune blistering disorders. These cytokines prime a patient having autoantibodies to develop blistering at tuberculin skin test site. Our patient did not develop bullous pemphigoid lesions at venepuncture sites. The development of bullous pemphigoid lesion at tuberculin skin test site but not at other trauma sites supports the possible role of purified protein derivative in inciting this koebnerization. We were unable to find any previous reports of bullous pemphigoid koebnerizing at the tuberculin skin test site. It is of utmost importance to identify this phenomenon and differentiate it from bullous reaction at tuberculin skin test site resulting from severe type IV hypersensitivity to purified protein derivative. The latter may represent latent tubercular infection and warrants antitubercular treatment, whereas bullous reaction resulting from koebnerization of autoimmune vesiculobullous dermatosis represents active disease, and in turn, requires treatment with immunosuppressive agents. Correct identification will help in proper patient management. Table 1 enlists salient points to differentiate between koebnerizing autoimmune bullous dermatosis and bullous type IV hypersensitivity reaction to purified protein derivative.
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